Showing results (81-90 of 109) with videos related to

Sort By:
Pageof 11
British Medical Journal|September 25, 1976
Histocompatibility antigens, autoantibodies, and immunoglobulins in alcoholic liver diseaseR J Bailey, N Krasner, A L Eddleston, et al.
Journal of Photochemistry and Photobiology. B, Biology|February 15, 2000
Photodynamic therapy using 5-aminolaevulinic acid for oesophageal adenocarcinoma associated with Barrett's metaplasiaW C Tan, C Fulljames, N Stone, et al.
Gynecologic Oncology|December 8, 2004
A phase II trial of weekly docetaxel in patients with platinum-resistant epithelial ovarian, primary peritoneal serous cancer, or fallopian tube cancerAnna Berkenblit, Michael V Seiden, Ursula A Matulonis, et al.
The Oncologist|January 31, 2023
Phase II Trials of Iniparib (BSI-201) in Combination with Gemcitabine and Carboplatin in Patients with Recurrent Ovarian CancerRichard T Penson, Allison J Ambrosio, Christin A Whalen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2009
Phase II evaluation of pemetrexed in the treatment of recurrent or persistent platinum-resistant ovarian or primary peritoneal carcinoma: a study of the Gynecologic Oncology GroupDavid S Miller, John A Blessing, Carolyn N Krasner, et al.
British Journal of Cancer|November 15, 2007
A Phase II study of trabectedin single agent in patients with recurrent ovarian cancer previously treated with platinum-based regimensC N Krasner, D S McMeekin, S Chan, et al.
Gynecologic Oncology|March 29, 2006
Phase I/II dose finding study of combination cisplatin and gemcitabine in patients with recurrent cervix cancerU A Matulonis, S Campos, L Duska, et al.
The British Journal of Surgery|March 1, 1979
A prospective randomized trial of vagotomy in chronic duodenal ulcerationC G Koffman, J B Elder, I E Gillespie, et al.
Gynecologic Oncology|June 30, 2006
Three sequential chemotherapy doublets for the treatment of newly diagnosed advanced müllerian malignancies: the modified triple doublet regimenU A Matulonis, S Campos, C N Krasner, et al.
Cancer Chemotherapy and Pharmacology|February 10, 2022
A phase I study of AZD2171 and Temsirolimus in patients with advanced gynecological malignanciesSusana M Campos, Suzanne Berlin, Carolyn N Krasner, et al.
Pageof 11